Callum Consultancy provides consulting services to:

• Small to medium-sized Pharmaceutical Companies that require expertise in dosage form development, testing and integration of activities with overall development programs and regulatory filings.
• Startup organizations or University Research Groups that need expertise in progressing novel assets to clinical evaluation and commercialization.
• Large Pharmaceutical organizations requiring expertise in a specific area of Drug Development or Regulatory filings.

Primary Services

• Dosage Form Design
• Technical Writing
• Regulatory Filings
• Training
• Due Diligence
• Expert Witness
• Lifecycle Management

Providing consulting expertise to small and growing pharmaceutical companies and research facilities throughout the world.

Callum Consultancy was founded by Patrick Crowley after retiring from GlaxoSmithKline as a Vice President in Pharmaceutical Development.

Patrick Crowley brings over 40 years of experience in Dosage Form Development in R&D-based organizations. He has helped design and obtain regulatory approval for 15 commercial products; including NCE's, Line Extensions, Semi Synthetics, Fermentation products and a Biopharm product.